DCPH Overview
Upcoming Projects (DCPH)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (DCPH)
-
Discussing the results from the phase III MOTION study of vimseltinib in TGCT(Tenosynovial giant cell tumor)
Ticker: DCPH
Executed On: Nov 30, 2023 at 01:30 PM EST -
A Third View: A discussion of KIT inhibitors in GIST, including ripretinib (Qinlock)
Ticker: DCPH
Executed On: Jan 25, 2023 at 12:00 PM EST -
A Second View: A discussion of KIT inhibitors in GIST, including ripretinib (Qinlock)
Ticker: DCPH
Executed On: Jan 19, 2023 at 04:00 PM EST -
A discussion of KIT inhibitors in GIST, including ripretinib (Qinlock)
Ticker: DCPH
Executed On: Jan 06, 2023 at 06:00 PM EST
Expired Projects (DCPH)
-
A 3rd Look - Understanding Disease Management in Systemic Mastocytosis - A Look at Pipeline Products from Blueprint & Deciphera
Tickers: BPMC, DCPH
Execute By: Sep 20, 2018
Upcoming & Overdue Catalysts (DCPH)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (DCPH)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
